Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts

Transplantation

Volumn 66, Issue 7, 1998, Pages 838-844

  Cooper, Matthew ^a   Lindholm, Paul ^a   Pieper, Galen ^a   Seibel, Ross ^a   Moore, Gail ^a   Nakanishi, Akemi ^a   Dembny, Kenneth ^a   Komorowski, Richard ^a   Johnson, Christopher ^a   Adams, Mark ^a   Roza, Allan M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PYRROLIDINE DITHIOCARBAMATE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; GRAFT REJECTION; GRAFT SURVIVAL; HEART MUSCLE; HEART TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT;

ANIMALS; ELECTRON SPIN RESONANCE SPECTROSCOPY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; NF-KAPPA B; NITRIC OXIDE; PYRROLIDINES; RATS; RATS, INBRED LEW; RATS, INBRED WF; THIOCARBAMATES; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0032532509     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810150-00005     Document Type: Article

References (43)

1. Halloran PF. The immune response to an organ transplant. In: Wood K, ed. The handbook of transplant immunology. Stokes Pages, Bucks, UK: MedSci Publications, 1995: 223.
2. Epstein FH. Mechanisms of disease: nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336(18): 1066.
3. Lai JH, Tan TH. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. J Biol Chem 1994; 269(48): 30077.
4. Lurie KG, Billingham ME, Jamieson SW, Harrison DC, Reitz BA. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation 1981; 31(1): 41.
5. Nakanishi A, Moore-Hilton G, Seibel R, Roza AM, Pieper GM. Electron spin resonance of nitric oxide signals in heterotopic cardiac allogeneic transplants. FASEB J 1997; 11: A477.
6. Lindholm PF, Reid RL, Brady JN. Extracellular Taxi protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells. J Virol 1992; 66(3): 1294.
7. Shannon MF, Himes SR, Coles LS. GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells. J Leukocyte Biol 1995; 57(5): 767.
8. Sehajpal PK, Sharma VK, Ingulli E, Stenzel KH, Suthanthiran M. Synergism between the CD3 antigen- and CD2 antigen-derived signals. Transplantation 1993; 55: 1118.
9. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141.
10. Rao A. NFATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J Leukocyte Biol 1995; 57: 536.
11. Chandrasekar B, Freeman GL. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett 1997; 401(1): 30.
12. Venkataraman L, Burakoff SJ, Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med 1995; 181(3): 1091.
13. Lindner V, Collins T. Expression of NF-κB and IκB-α by aortic endothelium in an arterial injury model. Am J Pathol 1996; 148(2): 427.
14. Chen F, Sun SC, Kuh DC, Gaydos LJ, Demers LM. Essential role of NF-κB activation in Silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 1995; 214(3): 985.
15. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994; 10: 405.
16. Flodström M, Welsh N, Eizirik DL. Cytokines activate the nuclear factor KB (NF-KB) and induce nitric oxide production in human pancreatic islets. FEBS Lett 1996; 385: 4.
17. Read MA, Whitely MZ, Williams AJ, Collins T. NF-κB and IκBα: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503.
18. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-KB activation and neutrophilic lung inflammation. J Immunol 1996; 157: 1630.
19. Kone BC, Schwobel J, Turner P, Mohaupt MG, Cangro CB. Role of NF-KB in the regulation of inducible nitric oxide synthase in an MTAL cell line. Am J Physiol 1995; 269(5 Pt 2): F718.
20. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269(7): 4705.
21. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 63.
22. Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA. Dithiocarbamates as potential inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175: 1181.
23. Wong HR, Finder JD, Wasserloos K, et al. Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. Am J Physiol 1996; 271(1 Pt 1): L166.
24. Kawai M, Nishikomori R, Jung EY, et al. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J Immunol 1995; 154: 2333.
25. Roza AM, Pieper G, Moore-Hilton G, Johnson CP, Adams MB. Free radicals in pancreatic and cardiac allograft rejection. Transplant Proc 1994; 26(2): 544.
26. Lehr HA, Messmer K. Rationale for the use of antioxidant vitamins in clinical organ transplantation. Transplantation 1996; 62(9): 1197.
27. Slakey DP, Roza AM, Pieper GM, Johnson CP, Adams MB. Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy. Transplantation 1993; 56: 1305.
28. Butt TR, Karathanasis SK. Transcription factors as drug targets: opportunities for therapeutic selectivity. Gene Expression 1995; 4: 319.
29. Levitzki A. Signal-transduction therapy: a novel approach to disease management. Eur J Biochem 1994; 226: 1.
30. Mattila PS, Ullman KS, Fiering S, et al. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 1990; 9(13): 4425.
31. McCaffrey PG, Kim PK, Valge-Archer VE, Sen R, Rao A. Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells. Nucleic Acids Res 1994; 22(11): 2134.
32. 2+ influx. J Immunol 1995; 157: 527.
33. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283.
34. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995; 270: 86.
35. H transcription, and Ig class switching. J Immunol 1996; 156: 183.
36. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science 1996; 274(5288): 782.
37. Goldman ME, Ransone LJ, Anderson DW, et al. SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo. Transplant Proc 1996; 28(6): 3106.
38. Lancaster JR Jr, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992; 267(16): 10994.
39. Langrehr JM, Müller AR, Bergonia HA, et al. Detection of nitric oxide by electron paramagnetic resonance spectroscopy during rejection and graft-versus-host disease after small-bowel transplantation in the rat. Surgery 1992; 112: 395.
40. Baker JE, Felix CC, Olinger GN, Kalyanaraman B. Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci USA 1988; 85: 2786.
41. Konorev EA, Kalyanaraman JB. S-Nitrosoglutathione induces formation of nitrosylmyoglobin in isolated hearts during cardioplegic ischemia: an electron spin resonance study. FEBS Lett 1996; 378: 111.
42. Luss, H, Li RK, Shapiro RA, et al. Dedifferentiated human ventricular myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS. J Mol Cell Cardiol 1997; 29: 1153.
43. Cooper M, Dembny K, Lindholm P, et al. Effects of nitric oxide scavenging and inhibition of NF-κB activity on cardiac allograft survival. Surg Forum 1997; 48: 500.